6
B. Mondal et al. / Tetrahedron xxx (xxxx) xxx
2.0 mmol) afforded the title compound 3C (181 mg, 48%) as a light
yellow oily liquid.
122.03, 127.71, 131.78, 141.59; Anal. C10H9BrO calcd, C: 53.36, H:
4.03; found, C: 53.37, H: 4.04.
1H NMR (200 MHz, CDCl3):
d 1.25 (s, 6H), 1.63 (br s, 1H), 2.15 (s,
1H), 2.56 (dd, 1H, J ¼ 13.8 Hz, J ¼ 10.5 Hz), 3.02 (dd, 1H, J ¼ 13.8 Hz,
4.12. 1-(3-Methoxy-phenyl)-but-3-yn-1-ol (3I) [24]
J ¼ 2.1 Hz), 3.51 (dd, 1H, J ¼ 10.5 Hz, J ¼ 2.1 Hz), 7.13e7.27 (m, 5H);
.
13C NMR (54.6 MHz, CDCl3):
d 24.64, 25.57, 36.70, 38.80, 70.10,
Using the general procedure but with 3-bromo-propyne 2A
(478 mg, 4.0 mmol) and 3-Methoxy benzaldehyde 1H (272 mg,
2.0 mmol) afforded the title compound 3I (317 mg, 90%) as a light
yellow oily liquid.
78.76, 89.44, 126.38, 128.50, 129.29, 139.21 Anal. (C13H16O) calcd. C:
82.94, H: 8.57; found, C: 82.84, H: 8.62.
4.7. 1-Phenyl-but-3-yn-1-ol (3D) [20]
1H NMR (400 MHz, CDCl3)
d
2.06 (t, 1H, J ¼ 2.6 Hz), 2.38 (d, 1H,
J ¼ 3.5 Hz), 2.64e2.59 (m, 2H), 3.80 (s, 3H), 4.83 (m, 1H), 6.82 (m,
Using the general procedure but with 3-bromo-propyne 2A
(476 mg, 4.0 mmol) and benzaldehyde 1C (212 mg, 2.0 mmol)
afforded the title compound 3D (196 mg, 67%) as a light yellow oily
liquid.
1H), 6.90e6.97 (m, 2H), 7.21e7.29 (m, 1H); 13C NMR (100.6 MHz,
CDCl3)
d 29.65. 55.45, 71.21, 72.46, 80.86, 111.49, 113.68, 118.22,
129.74, 144.35, 159.95, Anal. C11H12O2 calcd, C: 74.98, H: 6.86;
found, C: 74.99, H: 6.87.
1H NMR (400 MHz, CDCl3)
d
2.06 (t, 1H, J ¼ 2.8 Hz), 2.36 (s, 1H),
2.69e2.55 (m, 2H), 4.86 (td, 1H, J ¼ 6.5, 2.6 Hz), 7.44e7.21 (m, 5H),
13C NMR (100.6 MHz, CDCl3)
29.42, 70.94, 72.30, 80.62, 125.70,
d
4.13. 2-Hydroxy-2-phenyl-pent-4-ynoic acid methyl ester (3J)
127.96, 128.45, 142.39, Anal. (C10H10O) calcd, C: 82.16, H: 8.20, O:
10.94; found, C: 82.17, H: 8.21.
Using the general procedure but with 3-bromo-propyne 2A
(478 mg, 4.0 mmol) and Oxo-phenyl-acetic acid methyl ester1I
(328 mg, 2.0 mmol) afforded the title compound 3J (163 mg, 40%) as
a colorless oily liquid.
4.8. 1-(4-Chloro-phenyl)-but-3-yn-1-ol (3E) [21,22]
Using the general procedure but with 3-bromo-propyne 2A
(476 mg, 4.0 mmol) and 4-Chloro benzaldehyde 1D (281 mg,
2.0 mmol) afforded the title compound 3E (260 mg, 72%) as a light
yellow oily liquid.
1H NMR (400 MHz, CDCl3)
d
: 2.06 (t, 1H, J ¼ 2.4), 3.02 (ddd, 2H,
J ¼ 2.4, 16.6, 133.0),3.82 (s, 3H), 3.94 (s, 1H), 7.42e7.31 (m, 3H), 7.59
(d, 2H, J ¼ 8.2), 13C NMR (101 MHz, CDCl3)
d: 30.89, 53.55, 71.23,
79.00, 125.39, 128.44, 139.83, 173.93, Anal. C12H12O3 calcd, C: 70.57,
H: 5.92; found, C: 70.59, H: 5.93.
1H NMR (400 MHz, CDCl3):
d
2.06e2.07 (m, 1H), 2.58e2.61 (m,
2H) 4.82e4.85 (m, 1H), 7.25e7.36 (m, 4H); 13C NMR (100.6 MHz,
CDCl3): 29.59, 71.54, 71.62, 80.14, 127.15, 128.62, 133.69, 140.83;
d
4.14. 1-(3-Chloro-phenyl)-hex-3-yn-1-ol (3K)
Anal. (C10H9ClO) calcd, C: 66.49, H: 5.02; found, C: 66.50, H: 5.03.
Using the general procedure but with 1-Bromo-pent-2-yne 2C
(588 mg, 4.0 mmol) and 3-Chloro benzaldehyde 1J (281 mg,
2.0 mmol) afforded the title compound 3I (146 mg, 35%) as a
4.9. 1-(2-Chloro-phenyl)-but-3-yn-1-ol (3F)
Using the general procedure but with 3-bromo-propyne 2A
(478 mg, 4.0 mmol) and 2-Chloro benzaldehyde 1E (281 mg,
2.0 mmol) afforded the title compound 3F (260 mg, 72%) as a light
yellow oily liquid.
colorless oily liquid with (72 mg, 17%)
a
-Hydroxy-allene (3L). as a
¼ 1.14 (t,
colorless oily liquid; 1H NMR (500 MHz, CDCl3):
d
J ¼ 7.5 Hz, 3H), 2.18 (dt, J ¼ 7.5, 2.4 Hz, 1H), 2.21 (dt, J ¼ 7.5, 2.4 Hz,
1H), 2.55 (ddt, J ¼ 16.5, 7.7, 2.4 Hz, 1H), 2.62 (ddt, J ¼ 16.5, 4.8,
2.4 Hz, 1H), 4.81e4.78 (m, 1H), 7.29e7.24 (m, 3H), 7.42e7.40 (m,
1H NMR (200 MHz, CDCl3):
d 2.09 (s, 1H), 2.78e2.79 (m, 2H),
2.79e2.83 (m, 1H) 5.27e5.30 (m, 1H), 7.21e7.35 (m, 3H), 7.62e7.64
(m, 1H); 13C NMR (54.6 MHz, CDCl3): 29.84, 68.85, 71.33, 80.16,
127.19,127.22,129.06,129.55,131.83,139.84; Anal. (C10H9ClO) calcd,
C: 66.49, H: 5.02; found, C: 66.50, H: 5.03.
1H), 13C NMR (126 MHz, CDCl3):
d
¼ 12.1, 13.8, 29.8, 71.6, 74.5, 85.2,
123.6, 125.8, 127.6, 129.3, 134.0, 144.6, Anal. C12H13ClO calcd, C:
69.07, H: 6.28; found, C: 69.09, H: 6.29.
4.10. 1-(4-Methoxy-phenyl)-but-3-yn-1-ol (3G) [22,23]
4.15.
a-Hydroxy-allene (3L)
Using the general procedure but with 3-bromo-propyne 2A
(478 mg, 4.0 mmol) and 4-Methoxy benzaldehyde 1F (272 mg,
2.0 mmol) afforded the title compound 3G (300 mg, 85%) as a light
yellow oily liquid.
1HNMR (500 MHz, CDCl3):
d
¼ 0.99 (t, 3H, J ¼ 7.4 Hz), 1.92e1.76
(m, 2H), 5.07e5.01 (m, 2H), 5.11 (br s, 1H), 7.28e7.24 (m, 3H), 7.38
(ddd, 1H, J ¼ 2.1, 1.5, 0.7 Hz).
13C NMR (126 MHz, CDCl3):
d
¼ 11.7,20.5, 73.4, 80.2, 109.3, 124.6,
1H NMR (400 MHz, CDCl3)
d
2.07 (t, 1H, J ¼ 2.6 Hz), 2.30 (br s,
126.5, 127.6, 129.3, 134.0, 144.0, 203.8.
1H), 2.66e2.60 (m, 2H), 3.81 (s, 3H), 4.84 (t, 1H, J ¼ 6.4 Hz),
Anal. C12H13ClO calcd, C: 67.18, H: 6.66; found, C: 67.19, H: 6.68.
6.92e6.86 (m, 2H), 7.35e7.29 (m, 2H); 13C NMR (100.6 MHz, CDCl3)
d
29.61, 55.51, 71.08, 72.21, 81.03, 114.08, 127.23, 134.87, 159.56;
Acknowledgement
Anal. C11H12O2 calcd, C: 74.98, H: 6.86; found, C: 74.99, H: 6.87.
Financial support of this work by SERB-New Delhi, SR/FT/CS-
4.11. 1-(4-Bromo-phenyl)-but-3-yn-1-ol (3H) [23]
137/2011 dated 12.07.2012, and Science
Biotechnology-WB, 50(Sanc.)/ST/P/S&T/15G-10/2018
&
Technology and
dated
Using the general procedure but with 3-bromo-propyne 2A
(478 mg, 4.0 mmol) and 4-Bromo benzaldehyde 1G (370 mg,
2.0 mmol) afforded the title compound 3H (333 mg, 74%) as a light
yellow oily liquid.
30.01.2019 to UKR is gratefully acknowledged.
Appendix A. Supplementary data
1H NMR (400 MHz, CDCl3)
d
2.07e1.97 (m, 1H), 2.37 (br s, 1H),
2.66e2.50 (m, 2H), 4.85e4.72 (m, 1H), 7.29e7.15 (m, 2H), 7.51e7.36
(m, 2H); 13C NMR (100.6 MHz, CDCl3)
29.64, 71.58, 71.87, 80.34,
Supplementary data to this article can be found online at
d
Please cite this article as: B. Mondal et al., Synthesis and characterization of nanoꢀzinc wire using a self designed unit galvanic cell in aqueous